Serina Therapeutics, Inc.·4

Aug 20, 4:35 PM ET

Bailey Gregory 4

4 · Serina Therapeutics, Inc. · Filed Aug 20, 2024

Insider Transaction Report

Form 4
Period: 2024-08-15
Transactions
  • Purchase

    Common Stock

    2024-08-15$6.65/sh+6,400$42,57733,006 total
  • Purchase

    Common Stock

    2024-08-16$7.31/sh+6,400$46,78039,406 total
  • Purchase

    Common Stock

    2024-08-19$7.93/sh+6,400$50,76045,806 total
Footnotes (3)
  • [F1]The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
  • [F2]The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
  • [F3]The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Documents

1 file
  • 4
    ownership.xmlPrimary